<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04145414</url>
  </required_header>
  <id_info>
    <org_study_id>P/2019/425</org_study_id>
    <nct_id>NCT04145414</nct_id>
  </id_info>
  <brief_title>Cerebrospinal Fluid Movements Through Interventricular Foramina in Phase Contrast Magnetic Resonance Imaging (PC-MRI)</brief_title>
  <acronym>MLCSFIV</acronym>
  <official_title>Cerebrospinal Fluid Movements Through Interventricular Foramina in Phase Contrast Magnetic Resonance Imaging (PC-MRI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assess the reproductability of PC-MRI for cerebrospinal fluid movements through the
      interventricular foramina on volunteer subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is a monocentric interventional prospective study. Each subject will have to pass two MRI.
      Phase contrast MRI (PC-MRI) will be calibrated for each subject by assessing the optimal
      encoding velocity. Three sequences including the aqueduct and the two interventricular
      foramina (IVF) will be done. The signal will be analysed by syngo.via software after defining
      by two different investigators the region of interest (ROI) which correspond to the IVF or
      the aqueductal lumen. Descriptive statistics will test the intra-individual and
      inter-observer consistency based on 4 flow parameters.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 13, 2019</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PC-MRI procedure reproducibility</measure>
    <time_frame>week 6</time_frame>
    <description>Test-retest reproducibility of double mesures (2nd measure at +48 hours minimum +6 weeks maximum) of 4 cerebrospinal liquid (CSL) flow parameters during PC-MRI.
CSL flow through interventricular foramina will be measured within healthy volunteers, and 4 intraclass correlation coefficients (ICC) will be calculated.
The test-retest coefficient will be considered satisfactory if &gt; or = to 0.75 .</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>CSF Circulation Disorder</condition>
  <condition>Foramen; Monro, Obstruction</condition>
  <condition>Mri</condition>
  <arm_group>
    <arm_group_label>Cerebral magnetic resonance imaging x2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cerebral MRI performed at enrolment visit and at +6 weeks (maximum)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>Reproductiblitity test assessed with MRI for cerebrospinal fluid movements</description>
    <arm_group_label>Cerebral magnetic resonance imaging x2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mini-Mental State Examination score &gt; 28/30

        Exclusion Criteria:

          -  MRI contraindication

          -  Medical or surgical history related to following pathologies: nervous system disease,
             cardiac arrhythmia, cardiac or respiratory insufficiency.

          -  Long-term medical treatment

          -  Ongoing pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurent TATU, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Besançon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Noor HAMDAN, Int</last_name>
    <phone>+33381668235</phone>
    <email>hmdnnoor@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noor HAMDAN, Int</last_name>
      <email>hmdnnoor@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Laurent TATU, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 29, 2019</study_first_submitted>
  <study_first_submitted_qc>October 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2019</study_first_posted>
  <last_update_submitted>October 29, 2019</last_update_submitted>
  <last_update_submitted_qc>October 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CSF</keyword>
  <keyword>PC-MRI</keyword>
  <keyword>interventricular foramina</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

